BLUEX
Price
$40.28
Change
-$0.25 (-0.62%)
Updated
Nov 13 closing price
Net Assets
98.87M
RGEBX
Price
$83.30
Change
-$1.87 (-2.20%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

BLUEX vs RGEBX

Header iconBLUEX vs RGEBX Comparison
Open Charts BLUEX vs RGEBXBanner chart's image
AMG Veritas Global Real Return I
Price$40.28
Change-$0.25 (-0.62%)
VolumeN/A
Net Assets98.87M
American Funds Growth Fund of Amer R2E
Price$83.30
Change-$1.87 (-2.20%)
VolumeN/A
Net Assets340.4B
BLUEX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
BLUEX vs. RGEBX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLUEX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 340B vs. BLUEX (98.9M). BLUEX pays higher dividends than RGEBX: BLUEX (0.27) vs RGEBX (0.00). BLUEX was incepted earlier than RGEBX: BLUEX (35 years) vs RGEBX (11 years). BLUEX (1.24) is less costly to investors than RGEBX (1.09). BLUEX is a more actively managed with annual turnover of: 33.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than BLUEX: RGEBX (250) vs BLUEX (2000). RGEBX annual gain was more profitable for investors over the last year : 8.10 vs. BLUEX (4.00). RGEBX return over 5 years is better than : 36.65 vs. BLUEX (-30.32).
BLUEXRGEBXBLUEX / RGEBX
Total Expense Ratio1.161.09106%
Annual Report Gross Expense Ratio1.241.09114%
Fund Existence35 years11 years-
Gain YTD5.21819.21927%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets98.9M340B0%
Annual Yield % from dividends0.270.00-
Returns for 1 year4.008.1049%
Returns for 3 years16.3462.3926%
Returns for 5 years-30.3236.65-83%
Returns for 10 years19.1193.7820%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRUG60.150.91
+1.54%
Bright Minds Biosciences
SRPT18.000.02
+0.11%
Sarepta Therapeutics
WSBCP24.98N/A
N/A
WesBanco
XP19.21-0.59
-2.98%
XP
HKIT2.37-0.39
-14.13%
Hitek Global